XORTX Therapeutics XRTX
NASDAQ XRTX
$1.05 +0.06 (+6.38%)
As of: Oct 21, 2026 · 11:12 AM EDT

XORTX Therapeutics (XRTX) Operating Leases (2022 - 2026)

Updated

XORTX Therapeutics (XRTX) posted Operating Leases of $11,510 for the quarter ended Dec 31, 2023, up 0.2% from $11,484 a year earlier.

Analysis

XORTX Therapeutics (XRTX) Operating Leases (2022 - 2026) Analysis & Trends

Since the quarter ended Jun 30, 2022, XORTX Therapeutics has reported Operating Leases for 4 quarters.

  • In prior years, XORTX Therapeutics' Operating Leases was $11,509 in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2023 stands as the highest quarterly Operating Leases since the quarter ended Sep 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.91 Bn 1,098.50 Bn 19.71 Bn
2 Johnson & Johnson 613.69 Bn 532.22 Bn 17.26 Bn
3 AbbVie 503.05 Bn 476.16 Bn 12.70 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn
6 Astrazeneca 261.30 Bn 234.99 Bn 12.86 Bn
7 Amgen 235.86 Bn 191.25 Bn 7.24 Bn
8 Gilead Sciences 190.51 Bn 164.71 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 XORTX Therapeutics 946,927.00 -2.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 15,056.00
Dec 31, 2025 37,287.00
Sep 30, 2025 59,094.00
Jun 30, 2025 80,473.00
Mar 31, 2025 15,662.00
Dec 31, 2024 38,785.00
Sep 30, 2024 61,468.00
Jun 30, 2024 83,706.00
Dec 31, 2023 11,510.00
Dec 31, 2022 11,502.36
Sep 30, 2022 28,240.15
Jun 30, 2022 47,503.36
API Access

XORTX Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=XRTX&period=max&api_key=YOUR_API_KEY